Pediatric experts reveal the 10 research areas set to shape child health
From gene therapy and AI to vaccines, nutrition, and cancer care, pediatric research leaders outline where the next…
Could GLP-1 drugs help breast cancer patients live longer?
A major real-world study links GLP-1 receptor agonists to improved survival and lower recurrence risk in women with…
Diabetes, weight-loss drugs not a perfect fit?
Type 2 diabetes affects millions of people worldwide and now a new international study, jointly led by Adelaide…
Exercise or caffeine? Study finds neither clearly beats placebo for mental fatigue
A 20-minute cycling session raised heart rate, and caffeine raised physiological arousal, but neither clearly protected young adults…
GLP-1 drugs combined with surgery yield superior weight loss results
People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and bariatric surgery…
Food timing may shape how T cells respond to infection and therapy
A new study reveals how lipids released after a meal can durably boost T cell metabolism, translation, and…
How cost, access, and awareness barriers are slowing BRCA testing
Despite broader guidelines and life-saving targeted therapies, real-world evidence reveals persistent gaps and inequities in BRCA testing, raising…
GLP-1 drugs promise wider health benefits, but experts urge caution on use
As GLP-1 receptor agonists move beyond blood sugar and weight loss, a new review shows why clinicians must…
Targeting glutamine metabolism enhances CAR-macrophage cancer therapy
Tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) exhibit significant metabolic dysregulation, which impairs their antitumor function. Specifically,…
How the immune system may influence Alzheimer’s, Parkinson’s, and related diseases
A sweeping review shows how the brain’s immune defenses can both fight and fuel neurodegeneration, revealing why timing,…
Bayer receives MHRA approval for Kerendia® (finerenone) in adults with heart failure with LVEF ≥ 40 %
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for Kerendia® (finerenone), a non-steroidal, selective mineralocorticoid…
Molecular switch in neurons found to limit the regrowth of damaged axonal fibers
Researchers from the Icahn School of Medicine at Mount Sinai have discovered a molecular switch in neurons that…